RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers
- Supplementary File 1:
PDF-Document (PDF, 556 KiB)
Jones, W.D.; Michener, C.M.; Biscotti, C.; Braicu, I.; Sehouli, J.; Ganapathi, M.K.; Ganapathi, R.N. RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers. Cancers 2020, 12, 620. https://doi.org/10.3390/cancers12030620
Jones WD, Michener CM, Biscotti C, Braicu I, Sehouli J, Ganapathi MK, Ganapathi RN. RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers. Cancers. 2020; 12(3):620. https://doi.org/10.3390/cancers12030620
Chicago/Turabian StyleJones, Wendell D., Chad M. Michener, Charles Biscotti, Iona Braicu, Jalid Sehouli, Mahrukh K. Ganapathi, and Ram N. Ganapathi. 2020. "RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers" Cancers 12, no. 3: 620. https://doi.org/10.3390/cancers12030620